Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market

An ‘enigmatic asset’ in one of the most competitive areas of drug development.

By Madison Muller · Bloomberg

An ‘enigmatic asset’ in one of the most competitive areas of drug development.